Eswatini vs IDA total: Access to anti-retroviral drugs, female
Eswatini
98.0%
in 2024
IDA total
87.1%
in 2024
Eswatini rank
1st
IDA total rank
4th
Access to anti-retroviral drugs, female over time
- Eswatini
- IDA total
How they compare
Eswatini currently reports 98.0% against 87.1% in IDA total, a difference of 10.9%.
That makes Eswatini's figure about 1.1 times IDA total's.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was IDA total ahead.
Eswatini ranks 1st and IDA total ranks 4th of 141 countries.
Eswatini has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Eswatini | IDA total | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 7.7% | 5.5% | 2.2% | Eswatini |
| 2010s | 64.4% | 48.9% | 15.5% | Eswatini |
| 2020s | 97.4% | 80.9% | 16.5% | Eswatini |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Eswatini or IDA total?
- Eswatini, at 98.0% against 87.1% in IDA total as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Eswatini and IDA total?
- 10.9%, with Eswatini ahead.
- How many years of comparable data are there for Eswatini and IDA total?
- 25 years are reported by both, from 2000 to 2024.
- How do Eswatini and IDA total rank globally for access to anti-retroviral drugs, female?
- Eswatini ranks 1st and IDA total ranks 4th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.